The risk of drug resistance during long-acting antimicrobial therapy

The emergence of drug resistance during antimicrobial therapy is a major global health problem, especially for chronic infections like human immunodeficiency virus, hepatitis B and C, and tuberculosis. Sub-optimal adherence to long-term treatment is an important contributor to resistance risk. New l...

Descripción completa

Detalles Bibliográficos
Autores principales: Nande, Anjalika, Hill, Alison L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society 2022
Materias:
Biological Applications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653236/
https://www.ncbi.nlm.nih.gov/pubmed/36350211
http://dx.doi.org/10.1098/rspb.2022.1444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653236/
https://www.ncbi.nlm.nih.gov/pubmed/36350211
http://dx.doi.org/10.1098/rspb.2022.1444

Ejemplares similares